Loading…
Immunic, Inc. is projected to rise to $19.65 by 2027, a +41% move from its current price of $13.97. IMUX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $13.57 | $13.98 | $14.41 | +0.10% |
| Aug 4 | $13.41 | $14.00 | $14.61 | +0.20% |
| Aug 5 | $13.29 | $14.01 | $14.77 | +0.29% |
| Aug 6 | $13.20 | $14.02 | $14.90 | +0.39% |
| Aug 7 | $13.12 | $14.04 | $15.02 | +0.49% |
| Aug 8 | $13.05 | $14.05 | $15.14 | +0.59% |
| Aug 9 | $12.98 | $14.07 | $15.24 | +0.69% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $12.98 | $14.07 | $15.24 | +0.69% |
| Week 2 | $12.64 | $14.16 | $15.87 | +1.38% |
| Week 3 | $12.41 | $14.26 | $16.39 | +2.08% |
| Week 4 | $12.23 | $14.36 | $16.86 | +2.78% |
| Week 5 | $12.08 | $14.46 | $17.30 | +3.48% |
| Week 6 | $11.96 | $14.56 | $17.72 | +4.20% |
| Week 7 | $11.85 | $14.66 | $18.13 | +4.91% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Immunic, Inc. is a biotechnology company focused on selective oral immunology therapies for chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical and phase 2 clinical development for patients with relapsing and progressive multiple sclerosis; and moderate-to-severe ulcerative colitis.
Immunic, Inc. (IMUX) is a healthcare stock with a current price of $13.39 and a market capitalization of $182.39M. It holds the rank of 3647 among listed securities.
A major floor 37.0% below — a decisive break under it would weaken the trend.
The nearest floor, 6.6% below — buyers have tended to step in here.
The nearest ceiling, 10.3% above — a clean break opens room to run.
A major ceiling 18.1% above — clearing it would confirm fresh momentum.
Key IMUX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of IMUX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $13.63 | Buy | $13.81 | Buy |
| MA 10 | $14.11 | Sell | $14.02 | Sell |
| MA 20 | $14.51 | Sell | $14.25 | Sell |
| MA 50 | $14.19 | Sell | $13.86 | Buy |
| MA 100 | $12.77 | Buy | $12.73 | Buy |
| MA 200 | $10.08 | Buy | $11.38 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 47.10 | Neutral |
| Stoch RSI (14) | 47.82 | Neutral |
| CCI (20) | -62.82 | Neutral |
| Williams %R (14) | -56.40 | Info |
| MACD (12,26,9) | -0.18 | Sell |
| ROC (12) | -7.48 | Sell |
| Bollinger %B (20,2) | 0.30 | Neutral |
| Stochastic %K (14) | 43.60 | Neutral |
| TRIX (15) | 0.03 | Buy |
| Awesome (5,34) | -0.94 | Sell |
| Ultimate (7,14,28) | 38.91 | Neutral |
| Momentum (10) | -1.19 | Sell |
| Aroon Osc (25) | -84.00 | Sell |
| Hull MA (9) | 13.41 | Buy |
| ADX (14) | 15.96 | Neutral |
| ATR (14) | 0.36 | Info |
The near-term chart carries a bullish signal, with RSI(14) at 40 and the stock trading near key moving averages. The 50-day simple moving average is $14.05, while the 200-day simple moving average is $9.97. Support is noted at $13.07 and resistance at $15.41, framing a clear short-term range.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.83 | $13.97 | $20.50 | 0% | Neutral | |
| $15.52 | $19.65 | $26.41 | +41% | Bullish | |
| $17.44 | $22.81 | $31.94 | +63% | Bullish | |
| $18.61 | $24.98 | $36.12 | +79% | Bullish | |
| $18.51 | $25.44 | $37.78 | +82% | Bullish | |
| $20.57 | $28.87 | $43.88 | +107% | Bullish | |
| $23.71 | $33.94 | $52.66 | +143% | Bullish | |
| $28.52 | $41.59 | $65.76 | +198% | Bullish | |
| $31.92 | $47.37 | $76.21 | +239% | Bullish | |
| $33.55 | $50.65 | $82.79 | +263% | Bullish | |
| $49.53 | $80.78 | $141.15 | +478% | Bullish | |
| $83.44 | $155.77 | $299.73 | +10.2x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $5.83 | $13.97 | $17.61 | +0.00% |
| September 2026 | $12.91 | $15.32 | $18.73 | +9.64% |
| October 2026 | $12.77 | $15.27 | $18.90 | -0.28% |
| November 2026 | $12.79 | $15.39 | $19.22 | +0.73% |
| December 2026 | $13.45 | $16.28 | $20.50 | +5.78% |
Click any year to see its month-by-month IMUX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect IMUX to range from $5.83 to $20.50 through 2026. The $13.97 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The IMUX price prediction for 2027 points to an average of $19.65 (low $15.52, high $26.41) — a potential gain of +41% on today's $13.97. Buyers look set to stay in control over this stretch.
In 2028, IMUX is projected to trade between $17.44 and $31.94, averaging $22.81 — a potential gain of +63% from today's $13.97. That is up +16% on the projected 2027 average. Momentum favours further upside here.
Immunic, Inc.'s 2029 outlook centres on $24.98, within a $18.61 to $36.12 range. That is up +10% on the projected 2028 average. That marks a +79% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, IMUX could reach as high as $37.78, with a base case around $25.44 and support toward $18.51 — roughly +82% from $13.97. Momentum favours further upside here.
Expect IMUX to range from $20.57 to $43.88 through 2031. The $28.87 average target implies a +107% move from current prices. That is up +13% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The IMUX price prediction for 2032 points to an average of $33.94 (low $23.71, high $52.66) — a potential gain of +143% on today's $13.97. Momentum favours further upside here.
In 2033, IMUX is projected to trade between $28.52 and $65.76, averaging $41.59 — a potential gain of +198% from today's $13.97. That is up +23% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Immunic, Inc.'s 2034 outlook centres on $47.37, within a $31.92 to $76.21 range. That is up +14% on the projected 2033 average. That marks a +239% change versus current levels. Momentum favours further upside here.
By 2035, IMUX could reach as high as $82.79, with a base case around $50.65 and support toward $33.55 — roughly +263% from $13.97. Buyers look set to stay in control over this stretch.
Expect IMUX to range from $49.53 to $141.15 through 2040. The $80.78 average target implies a +478% move from current prices. That is up +59% on the projected 2035 average. Momentum favours further upside here.
The IMUX price prediction for 2050 points to an average of $155.77 (low $83.44, high $299.73) — a potential gain of +10.2x on today's $13.97. Buyers look set to stay in control over this stretch.
Investing $1,000 in IMUX today (≈ 71.581961 IMUX) could be worth
$11,150.08
+$10,150.08 (+1015%) by 2050 · US Dollar
Based on the average projected IMUX price of $155.77 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in IMUXwould be worth at today's price.
$1,000 invested in IMUX on Jul 31, 2025 (≈ 106.382983 IMUX) would be worth
$1,486.17
+$486.17 (+48.6%) today · 1.49× · US Dollar
Based on a IMUX entry price of $9.4 vs. today's $13.97.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $13.39 | $1,043.32 | +4.3% |
| 1 month ago | $14.81 | $943.28 | -5.7% |
| 3 months ago | $9.65 | $1,447.67 | +44.8% |
| 6 months ago | $6.54 | $2,136.09 | +113.6% |
| 1 year ago | $9.4 | $1,486.17 | +48.6% |
| All time (5.0y) ago | $90.4 | $154.54 | -84.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our IMUX forecast.
Our base-case forecast reaches $28.00 around 2031.
Implied market cap at $28.00: $381.4M
The multi-year forecast shows upside potential with a path of higher averages and bullish sentiment after 2026. In 2026, the average price is $13.39 with a min of $5.83 and a max of $19.83. By 2027 the average rises to $18.66 (ROI 39.4; sentiment BULLISH), and by 2028 to $21.65 (ROI 61.7; sentiment BULLISH).
In 2030 the average is $23.75 (ROI 77.4; sentiment BULLISH) with a max of $35.11. By 2040 the average reaches $74.18 (ROI 454; sentiment BULLISH) and by 2050 it is $142.12 (ROI 961.4; sentiment BULLISH). The forecast also lists higher max prices over time, including $128.59 in 2040 and $270.90 in 2050, underscoring substantial upside potential alongside notable uncertainty.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $23.75, a min of $17.36, and a max of $35.11, with an ROI of 77.4 and a sentiment of BULLISH.
Forecasts indicate bullish sentiment from 2027 through 2050 with rising average prices (e.g., $18.66 in 2027, $23.75 in 2030, $142.12 in 2050) and increasing ROI (e.g., 39.4 in 2027 up to 961.4 in 2050). These are estimates, not guarantees.
Yes, the forecast shows higher max values later in the horizon, with a max of $128.59 in 2040 and $270.90 in 2050. The early years cap at a max of $35.11 in 2030.
Current price is $13.39 and market cap is $182.39M.
The 30-day range is from $11.02 to $16.28.
Immunic, Inc. Community Discussion
0Share your Immunic, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.